Home > Research > Publications & Outputs > Bayesian inference for the Markov-modulated Poi...

Electronic data

  • MMPP_HMMfinal

    Accepted author manuscript, 996 KB, PDF document

    Available under license: CC BY: Creative Commons Attribution 4.0 International License

View graph of relations

Bayesian inference for the Markov-modulated Poisson process with an outcome process

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Forthcoming

Standard

Bayesian inference for the Markov-modulated Poisson process with an outcome process. / Luo, Yu; Sherlock, Chris.
In: Journal of the Royal Statistical Society: Series C (Applied Statistics), 03.03.2025.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Luo, Y & Sherlock, C 2025, 'Bayesian inference for the Markov-modulated Poisson process with an outcome process', Journal of the Royal Statistical Society: Series C (Applied Statistics).

APA

Luo, Y., & Sherlock, C. (in press). Bayesian inference for the Markov-modulated Poisson process with an outcome process. Journal of the Royal Statistical Society: Series C (Applied Statistics).

Vancouver

Luo Y, Sherlock C. Bayesian inference for the Markov-modulated Poisson process with an outcome process. Journal of the Royal Statistical Society: Series C (Applied Statistics). 2025 Mar 3.

Author

Luo, Yu ; Sherlock, Chris. / Bayesian inference for the Markov-modulated Poisson process with an outcome process. In: Journal of the Royal Statistical Society: Series C (Applied Statistics). 2025.

Bibtex

@article{b774cd695d564145863ede30f75b0e55,
title = "Bayesian inference for the Markov-modulated Poisson process with an outcome process",
abstract = "In medical research, understanding changes in outcome measurements is crucial for inferring shifts in health conditions. However, traditional methods often struggle with large, irregularly longitudinal data and fail to account for the tendency of individuals in poorer health to interact more frequently with the healthcare system. Additionally, clinical data can lack information on terminating events like death. To address these challenges, we start from the continuous-time hidden Markov model which models observed data as outcomes influenced by latent health states. Our extension incorporates a point process to account for the impact of health states on observation timings and includes a {"}death{"} state to model unobserved terminating events through a Poisson process, where transition rates depend on the latent health state. This approach captures both the severity of the disease and the timing of healthcare interactions. We present an exact Gibbs sampler procedure that alternates between sampling the latent health state paths and the model parameters. By including the {"}death{"} state, we mitigate biases in parameter estimation that would arise from solely modelling {"}live{"} health states. Simulation studies demonstrate that the proposed Gibbs sampler performs effectively. We apply our method to Canadian healthcare data, offering valuable insights for healthcare management.",
keywords = "Claim data; Hidden Markov models,; Markov modulated Poisson process; Gibbs sampler",
author = "Yu Luo and Chris Sherlock",
year = "2025",
month = mar,
day = "3",
language = "English",
journal = "Journal of the Royal Statistical Society: Series C (Applied Statistics)",
issn = "0035-9254",
publisher = "Wiley-Blackwell",

}

RIS

TY - JOUR

T1 - Bayesian inference for the Markov-modulated Poisson process with an outcome process

AU - Luo, Yu

AU - Sherlock, Chris

PY - 2025/3/3

Y1 - 2025/3/3

N2 - In medical research, understanding changes in outcome measurements is crucial for inferring shifts in health conditions. However, traditional methods often struggle with large, irregularly longitudinal data and fail to account for the tendency of individuals in poorer health to interact more frequently with the healthcare system. Additionally, clinical data can lack information on terminating events like death. To address these challenges, we start from the continuous-time hidden Markov model which models observed data as outcomes influenced by latent health states. Our extension incorporates a point process to account for the impact of health states on observation timings and includes a "death" state to model unobserved terminating events through a Poisson process, where transition rates depend on the latent health state. This approach captures both the severity of the disease and the timing of healthcare interactions. We present an exact Gibbs sampler procedure that alternates between sampling the latent health state paths and the model parameters. By including the "death" state, we mitigate biases in parameter estimation that would arise from solely modelling "live" health states. Simulation studies demonstrate that the proposed Gibbs sampler performs effectively. We apply our method to Canadian healthcare data, offering valuable insights for healthcare management.

AB - In medical research, understanding changes in outcome measurements is crucial for inferring shifts in health conditions. However, traditional methods often struggle with large, irregularly longitudinal data and fail to account for the tendency of individuals in poorer health to interact more frequently with the healthcare system. Additionally, clinical data can lack information on terminating events like death. To address these challenges, we start from the continuous-time hidden Markov model which models observed data as outcomes influenced by latent health states. Our extension incorporates a point process to account for the impact of health states on observation timings and includes a "death" state to model unobserved terminating events through a Poisson process, where transition rates depend on the latent health state. This approach captures both the severity of the disease and the timing of healthcare interactions. We present an exact Gibbs sampler procedure that alternates between sampling the latent health state paths and the model parameters. By including the "death" state, we mitigate biases in parameter estimation that would arise from solely modelling "live" health states. Simulation studies demonstrate that the proposed Gibbs sampler performs effectively. We apply our method to Canadian healthcare data, offering valuable insights for healthcare management.

KW - Claim data; Hidden Markov models,; Markov modulated Poisson process; Gibbs sampler

M3 - Journal article

JO - Journal of the Royal Statistical Society: Series C (Applied Statistics)

JF - Journal of the Royal Statistical Society: Series C (Applied Statistics)

SN - 0035-9254

ER -